Morphic Therapeutic, Inc.

Tyler Day

Aleksey I Gerasyuto

Blaise S Lippa

Dawn M Troast

Fu-Yang Lin

Kristopher N Hahn

Cheng Zhong

Byungchan Kim

Bruce Nelsen Rogers

Matthew Gregory Bursavich

Bryce Alden Harrison

Kyle D Konze

Mats A Svensson

Brian Sosa

James E Dowling

Eugene R Hickey

Alexey Alexandrovich Lugovskoy

Robert Zahler

Salma Rafi

Qi Qiao

Andrea Bortolato

Dan Cui

Evelyne Houang

Angrea Bortolato

Disclosed are small molecule inhibitors of αvβ6 integrin, and methods of using them to treat a number of diseases and conditions.

Inhibiting (α-v)(β-6) integrin

Disclosed are small molecule antagonists of α4β7 integrin, and methods of using them to treat a number of specific diseases or conditions.

Antagonists of human integrin α4β7

Disclosed are small molecule inhibitors of &#x3b1;v&#x3b2;6 integrin, and methods of using them to treat a number of diseases and conditions.

Inhibiting (&#x3b1;-v)(&#x3b2;-6) integrin

Disclosed are small molecule antagonists of human &#x3b1;&#x3b2;integrin, and methods of using them to treat a number of diseases and conditions.

Inhibiting human integrin (alpha-4) (beta-7)

Disclosed are small molecule antagonists of &#x3b1;4&#x3b2;7 integrin, and methods of using them to treat a number of specific diseases or conditions.

Antagonists of human integrin (&#x3b1;4)(&#x3b2;7)

Inhibiting human integrin (&#x3b1;-4) (&#x3b2;-7)

Antagonists of human integrin &#x3b1;4&#x3b2;7

Growing community of inventors

New York, NY, United States of America

Tyler Day